Latest Non-Hodgkin lymphoma Stories
Lack of Access and Financial Burden May Contribute to Increased Mortality, CPIC Researchers Find Fremont, CA (PRWEB) August 19, 2014 Despite advances
Participants to Produce Strategic Roadmap for Accelerating Lymphoma Treatment Advances WASHINGTON, Aug.
LONDON, July 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
SEATTLE, July 21, 2014 /PRNewswire/ -- CTI BioPharma Corp.
-COMMUNITY LEADERS RAISED $30.5 MILLION TO HELP FIND CANCER CURES- WHITE PLAINS, N.Y., July 17, 2014 /PRNewswire/ -- A Chicago man and Los Angeles woman raised $386,284 and $343,962,
Failure to get the best treatment and variations in the quality of care are the most likely reasons why survival for blood cancer patients still varies widely between regions within Europe.
HIV-infected people diagnosed with cancer are two to four times more likely to go untreated for their cancer compared to uninfected cancer patients.
MabThera SC offers a faster administration time for patients in Europe while potentially saving valuable time for health systems SAN DIEGO, June 25, 2014 /PRNewswire/ -- Halozyme Therapeutics,
CAMBRIDGE, Mass., June 10, 2014 /PRNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company
Follicular lymphoma, a B cell lymphoma, is an incurable form of non-Hodgkin lymphoma that is diagnosed each year in 120,000 people worldwide.
- Emitting flashes of light; glittering.